Clinical Trial Update: Evaluation of a New Medical Device AL539 in Patients With Obstructive Apneas Sleep Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluating the AL539 medical device for obstructive sleep apnea syndrome has been reported. The sponsor is Air Liquide Santé Internat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea Syndrome

Drugs mentioned

• AL539

Snippet

Sponsor: Air Liquide Santé International | Conditions: Obstructive Sleep Apnea Syndrome | NA | Status: COMPLETED